Several studies have shown an association between toxicity and UGT1A genetic variations in CRC and lung cancer, but few studies have reported gastric cancer patients’ UGT1A polymorphisms and irinotecan toxicity [12,13]. The gene discussed is UGT1A1; the disease is lung cancer.